Author:
Oliveira Pedro,Zejnilovic Leid,Canhão Helena,von Hippel Eric
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference26 articles.
1. Rodwell C, Aymé S, eds, “2014 Report on the State of the Art of Rare Disease Activities in Europe”, July 2014, European Union. ( http://www.eucerd.eu/upload/file/Reports/2014ReportStateofArtRDActivities.pdf ).
2. Westermark K, Holm BB, Söderholm M, Llinares-Garcia J, Rivière F, Aarum S, et al. European regulation on orphan medicinal products: 10 years of experience and future perspectives. Nat Rev Drug Discov. 2011;10:341–9.
3. Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Rare diseases, orphan drugs, and their regulation in Asia: current status and future perspectives. Intractable Rare Dis Res. 2012;1(1):3–9.
4. Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, et al. Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab. 2009;96:20–6.
5. Acemoglu D, Linn J. Market size in innovation: theory and evidence from the pharmaceutical industry. Q J Econ. 2004;119(August):1049–90.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献